top of page

Less Invasive Lymph Node Surgery in Breast Cancer: What Researchers Are Studying

Writer: Women's Cancer Research Foundation
Women's Cancer Research Foundation
3 hours ago
2 min read
Graphic featuring Bram Goldstein, Ph.D., for “A Clinical Perspective: Less Invasive Lymph Node Surgery in Breast Cancer—What Researchers Are Studying.”

Breast cancer surgery continues to evolve not only in how cancer is treated, but also in how the effects of treatment may be reduced. A recent review examines endoscopic axillary lymphadenectomy, a minimally invasive approach being studied for selected patients who still require the removal of lymph nodes from the underarm area.


Bram Goldstein, Ph.D., President and Senior Clinical Fellow of the Women’s Cancer Research Foundation, provides clinical context on the technique, its potential benefits, and the research still needed.


Axillary lymphadenectomy (a procedure used to evaluate whether cancer has spread beyond the primary tumor) for breast cancer remains a necessary surgical procedure in selected cases. Associated morbidity includes lymphedema (swelling arising from the lymph nodes), pain, and sensory or mobility impairments.


Within the realm of breast cancer innovation, minimally invasive surgery has extended to the axilla (the area under the armpit or underarm) through endoscopic axillary lymphadenectomy (EALND). A recent review article from Cancers sought to summarize the evolution of the technique, clinical outcomes, and current evidence.


Available studies suggest that EALND may offer benefits in terms of postoperative morbidity while maintaining adequate surgical outcomes. However, due to the limited number of high-quality studies and the ongoing evolution of this technique, further well-designed research, including studies with longer follow-up, is needed to provide more robust evidence regarding its clinical and oncological outcomes.


Why This Breast Cancer Research Matters

Advances in cancer care are not limited to new medications. They also include improving surgical approaches to reduce complications and protect quality of life.


The available evidence surrounding endoscopic axillary lymphadenectomy is encouraging, but it remains limited. Continued research with well-designed studies and longer follow-up will help determine the role this minimally invasive approach may have in breast cancer surgery.



Medical note: This article is intended for educational purposes only and does not provide medical advice, diagnosis, or individualized screening or treatment recommendations. Please consult a qualified healthcare professional about personal health concerns.

Comments


FORMERLY KNOWN AS THE NANCY YEARY WOMEN'S CANCER RESEARCH FOUNDATION
IN MEMORY OF NANCY AND BOB YEARY

ABOUT US 

Since 1985, the physicians and researchers at the WCRF have been at the forefront of pioneering clinical research, aimed at enhancing cure rates among women diagnosed with breast, ovarian, uterine, and cervical cancers. WCRF actively engages in designing, conducting, and disseminating groundbreaking research focused on cutting-edge medical treatments.


Furthermore, WCRF serves as a vital hub for both foundational and applied research, as well as education, pertaining to the latest advancements in the treatment of breast and gynecologic cancers. In addition to conducting and publishing original research, the WCRF, provides valuable clinical information to physicians and patients alike.
 

 

Subscribe to Our Newsletter

Thanks for submitting!

CONTACT 

T: 949-642-5165

F: 949-646-7157

​

​

699 Diamond Street
Laguna Beach, CA 92651

  • Womens Cancer Research Foundation on X
  • LinkedIn
  • Facebook
  • YouTube
  • Instagram
Wpmen's Cancer Research Foundation

© 2026 Women's Cancer Research Foundation All rights reserved.

Website design by Tribe of Digital Natives

bottom of page